Technical Analysis for NARI - Inari Medical, Inc.

Grade Last Price % Change Price Change
F 41.63 2.41% 0.98
NARI closed up 2.41 percent on Monday, March 18, 2024, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Flat

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Bullish Engulfing Bullish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 2.41%
Hammer Candlestick Bullish 2.41%
Lizard Bullish Bullish Day Trade Setup 2.41%
NR7 Range Contraction 2.41%
Narrow Range Bar Range Contraction 2.41%
Doji - Bullish? Reversal 2.41%

   Recent Intraday Alerts

Alert Time
10 DMA Resistance about 18 hours ago
Rose Above 10 DMA about 19 hours ago
Up 3% about 19 hours ago
Up 2% about 20 hours ago
60 Minute Opening Range Breakout about 20 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Inari Medical, Inc. Description

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari is focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Disease Catheter FDA Hematology Quality Of Life Veins Thrombosis Angiology Blood Clots Deep Vein Thrombosis Embolectomy Pulmonary Embolism Thrombectomy Thrombus Venous Diseases Venous Thrombosis

Is NARI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 71.81
52 Week Low 39.8987
Average Volume 927,970
200-Day Moving Average 59.46
50-Day Moving Average 54.05
20-Day Moving Average 47.77
10-Day Moving Average 41.76
Average True Range 2.14
RSI (14) 28.57
ADX 49.93
+DI 10.84
-DI 36.70
Chandelier Exit (Long, 3 ATRs) 53.11
Chandelier Exit (Short, 3 ATRs) 46.32
Upper Bollinger Bands 62.29
Lower Bollinger Band 33.25
Percent B (%b) 0.29
BandWidth 60.80
MACD Line -4.36
MACD Signal Line -4.03
MACD Histogram -0.3351
Fundamentals Value
Market Cap 2.4 Billion
Num Shares 57.6 Million
EPS -0.05
Price-to-Earnings (P/E) Ratio -832.60
Price-to-Sales 7.22
Price-to-Book 7.50
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.39
Resistance 3 (R3) 44.28 43.26 43.93
Resistance 2 (R2) 43.26 42.55 43.31 43.78
Resistance 1 (R1) 42.44 42.12 42.85 42.55 43.62
Pivot Point 41.42 41.42 41.62 41.47 41.42
Support 1 (S1) 40.60 40.71 41.01 40.71 39.64
Support 2 (S2) 39.58 40.28 39.63 39.48
Support 3 (S3) 38.76 39.58 39.33
Support 4 (S4) 38.87